Navigation Links
Unigene Laboratories Granted US Patent for Peptide-Based Technology for Treatment of Obesity
Date:1/11/2012

clinical studies of UGP281 before the end of 2012; the lead molecule for the Type 2 diabetes indication will be selected by the Company with Nordic, early-stage preclinical studies will be conducted and the preclinical results of a lead molecule will be reported in the second half of 2012; at least one feasibility study will convert into a high-value milestone and royalty payment licensing agreement over the next 6-9 months; Cara will report the results from its Phase 1 study in the first quarter of 2012; the Company is well positioned to capitalize on the numerous opportunities that its oral peptide delivery platform and pipeline are expected to realize in 2012; the Company will secure a development partner and licensee for its oral PTH program and, if so, whether it will become a game-changing treatment option for the estimated 75 million people in Europe, the US and Japan who are impacted by osteoporosis; the Company and its stockholders will reap rewards and achieve substantial growth in 2012; and the Company's current cash flow will be sufficient to fund its business operations into the second half of 2012.  We have based these forward-looking statements on our current expectations and projections about future events, including our cash flow projections. These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various risk factors. These known and unknown risk factors include, but are not limited to: the delay in obtaining or the failure to obtain regulatory approvals for our products and the products of our licensees that may generate royalty and milestone payments to us, our ability to achieve product sales and royalties, competition, our dependence on other companies to commercialize, manufacture and sell
'/>"/>
SOURCE Unigene Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Unigene Provides 2012 Business Outlook
2. Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
3. Unigenes Proprietary Peptelligence™ Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist
4. Unigene Strengthens Board with the Appointment of Walgreens Executive, Thomas J. Sabatino, Jr.
5. Unigene Reports Third Quarter 2011 Financial Results
6. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
7. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
8. Bedford Laboratories™ Issues Guidance on 2011 Voluntary Recall of Polymyxin B for Injection USP and Vecuronium Bromide for Injection Related to Glass Particulates
9. Quest Diagnostics Completes Acquisition of S.E.D. Medical Laboratories
10. IDEXX Laboratories to Present at J.P. Morgan Healthcare Conference
11. Abaxis Veterinary Reference Laboratories Now Offering Quantitative Lyme Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Today, the Partnership for Prescription Assistance ... research companies, unveiled a redesigned website ... and caregivers with faster, easier access to information ... assistance programs. Since its launch ... engage, educate and empower patients and caregivers to ...
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, ... stem cell-derived islet replacement therapy for the treatment of ... Dr. Eugene Brandon , Director of Strategic Relations ... annual summit showcases the latest in type 1 diabetes ... presentation are as follows: , , , ...
(Date:3/3/2015)... VIEW, Calif. , March 3, 2015 /PRNewswire/ ... enhanced drug discovery market, Frost & Sullivan recognizes ... & Sullivan Award for Technology Leadership. Neopeutics has ... clients a robust, cost-effective, and easily adaptable set ... agents that are catalogued as failing compounds in ...
Breaking Medicine Technology:Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 2ViaCyte to Present at JDRF TypeOneNation Research Summit 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 3Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 4Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 5
(Date:3/3/2015)... 03, 2015 Retrofit , the ... America’s leading corporations, today announces the appointment of its ... positions. CEO Mary Pigatti has recruited technology, ... employee engagement for the fast-growing company, which was recently ... for 2015. , “Retrofit is thrilled to announce ...
(Date:3/3/2015)... March 3, 2015, My Positive Perspective host was joined ... a unique one, not just because it was the first ... men who were both faced with monumental obstacles after being ... episode, Deierlein said to Collins, “I had the opportunity to ... very excited that you could join me on the set ...
(Date:3/3/2015)... 03, 2015 eMedEvents, a searchable ... medical education (CME) credit information, has officially been ... was initially launched in the United States (December ... kind in the field of healthcare conference technology ... this Denver, Colorado-based start-up company was successful as ...
(Date:3/3/2015)... FAYETTEVILLE, Ark. (PRWEB) March 03, 2015 ... , announced that Mr. William A. Breukelman has been ... has recently completed development of the first fully integrated ... is uniquely capable of analyzing the three-dimensional motion of ... and then comparing the analysis at 15,300 points to ...
(Date:3/3/2015)... York, NY (PRWEB) March 03, 2015 Ticket ... tickets for her 2015 tour. This well-known ticket ... added savings. , Arguably the biggest name in the music ... when Madonna performs on the “Rebel Heart Tour.” Madonna, fresh ... month will kick off her latest tour on August 29th ...
Breaking Medicine News(10 mins):Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 2Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 4Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:eMedEvents Launches Online Medical Conference, Speaker and CME Platform in India 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 3Health News:Cheap Madonna Tickets: Madonna Presale Tickets in Miami, New York, Brooklyn, Chicago, San Jose, Toronto, Edmonton & Vancouver Now Available at TicketDown.com 2Health News:Cheap Madonna Tickets: Madonna Presale Tickets in Miami, New York, Brooklyn, Chicago, San Jose, Toronto, Edmonton & Vancouver Now Available at TicketDown.com 3
... more often in spinal fusions, but experts worry about costs ... A relatively new agent that stimulates the creation of new ... used in the United States, although costs and some complication ... new study reports. , The therapeutic agent, known as bone-morphogenic ...
... disease-linked factors don,t perform better than standard criteria, study ... biomarkers of cardiac risk, such as inflammation-linked C-reactive ... older, established factors such as smoking, obesity, high cholesterol ... newer blood-borne markers have been touted as a better ...
... decode the human genome and the information becomes publicly ... multiplying. Scientists at the National Institutes of Health were ... They evaluated responses to an online test among smokers ... variant associated with risk for lung cancer. The results, ...
... Study finds increased risk for postmenopausal women , ... blood pressure, elevated glucose and other components of metabolic ... cancer, a new study suggests. , Metabolic syndrome, also ... of such conditions as abdominal obesity, high blood glucose ...
... DALLAS, June 30 At the 8th Annual Spirit ... of North Texas (EFNT) recognized The Beryl Companies, the ... healthcare organizations, as the North Star 2009 Inductee. This ... example and show the importance of giving back to ...
... June 30 Every summer, the bloodsuckers send Canadians swatting ... good reason. , , More than just creatures ... and cause human flesh to swell and redden. An even ... , , While many Canadians warily use conventional ...
Cached Medicine News:Health News:Assessment of Bone Growth Stimulator Is Mixed 2Health News:Assessment of Bone Growth Stimulator Is Mixed 3Health News:Newer Blood Tests May Not Improve Heart Risk Assessment 2Health News:Newer Blood Tests May Not Improve Heart Risk Assessment 3Health News:Possible benefit from online genetic testing for lung cancer 2Health News:Metabolic Syndrome May Make Breast Cancer More Likely 2Health News:Beryl Receives Entrepreneurs Foundation of North Texas North Star Recognition 2
Cushing bayonet....
Straight, blunt tips....
Angled, pointed, with attached cable for Valleylab and other brands generators....
Autoclavable reusable pencil for Aaron 800 & 1200 - comes with generator or 1/box....
Medicine Products: